{
    "q": [
        {
            "docid": "170417_4",
            "document": "T cell . T helper cells (T cells) assist other white blood cells in immunologic processes, including maturation of B cells into plasma cells and memory B cells, and activation of cytotoxic T cells and macrophages. These cells are also known as CD4 T cells because they express the CD4 glycoprotein on their surfaces. Helper T cells become activated when they are presented with peptide antigens by MHC class II molecules, which are expressed on the surface of antigen-presenting cells (APCs). Once activated, they divide rapidly and secrete small proteins called cytokines that regulate or assist in the active immune response. These cells can differentiate into one of several subtypes, including T1, T2, T3, T17, T9, or T, which secrete different cytokines to facilitate different types of immune responses. Signalling from the APC directs T cells into particular subtypes.",
            "score": 222.7775913476944
        },
        {
            "docid": "7244534_2",
            "document": "NFAT . Nuclear factor of activated T-cells (NFAT) is a family of transcription factors shown to be important in immune response. One or more members of the NFAT family is expressed in most cells of the immune system. NFAT is also involved in the development of cardiac, skeletal muscle, and nervous systems. NFAT was first discovered as an activator for the transcription of interleukin-2 in the T cells, as a regulator for T cell immune response, but has since been found to play an important role in regulating many other body systems. NFAT transcription factors are involved in many normal body processes as well as in development of several diseases, such as inflammatory bowel diseases and several types of cancer. NFAT is also being investigated as a drug target for several different disorders.",
            "score": 227.30321145057678
        },
        {
            "docid": "1920949_2",
            "document": "FOXP3 . FOXP3 (forkhead box P3), also known as scurfin, is a protein involved in immune system responses. A member of the FOX protein family, FOXP3 appears to function as a master regulator of the regulatory pathway in the development and function of regulatory T cells. Regulatory T cells generally turn the immune response down. In cancer, an excess of regulatory T cell activity can prevent the immune system from destroying cancer cells. In autoimmune disease, a deficiency of regulatory T cell activity can allow other autoimmune cells to attack the body's own tissues.",
            "score": 241.504243850708
        },
        {
            "docid": "458424_22",
            "document": "National Eye Institute . NEI researchers conducted a study that looked at the bacteria in the gut and how it protects the natural flora. Findings from studies suggest that this characteristic may be similar to how immune cells attack the eye in autoimmune eye diseases such as uveitis. Autoimmune uveitis is an inflammatory eye disease where the immune cells attack proteins in the eye. By studying how immune cells, also known as T cells, attack other parts of the body, researchers may gain further information on how the T cells are activated in the eye. It will also allow researchers to understand the disease better and develop treatments or therapies.",
            "score": 218.37807965278625
        },
        {
            "docid": "32523145_8",
            "document": "CD8+ cell . CD8+ T cells have been found to play different roles in certain diseases, such as in HIV infection and in Type 1 diabetes. HIV over time has developed many strategies to evade the host cell immune system. For example, HIV has adopted very high mutation rates to allow them to escape recognition by CD8+ T cells. They are also able to down-regulate expression of surface MHC Class I proteins of cells that they infect, in order to further evade destruction by CD8+ T cells. If CD8+ T cells cannot find, recognize and bind to infected cells, the virus will not be destroyed and will continue to grow. Furthermore, it has been recently discovered that CD8+ T cells play a critical role in Type 1 diabetes. It was previously thought that this autoimmune disease was exclusively controlled by CD4+ cells - but recent studies in a diabetic mouse model showed that CD8+ T cells also engaged in the destruction of insulin-producing pancreatic cells.",
            "score": 220.69001603126526
        },
        {
            "docid": "14756417_2",
            "document": "Programmed cell death protein 1 . Programmed cell death protein 1, also known as PD-1 and CD279 (cluster of differentiation 279), is a protein found on the surface of cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self tolerance by suppressing T cell inflammatory activity. This prevents autoimmune diseases, but it can also prevent the immune system from killing cancer cells.",
            "score": 223.7049126625061
        },
        {
            "docid": "1920949_7",
            "document": "FOXP3 . Further work has shown that T cells are more plastic in nature than originally thought. This means that the use of regulatory T cells in therapy may be risky, as the T regulatory cell transferred to the patient may change into T helper 17 (Th17) cells, which are pro-inflammatory rather than regulatory cells. Th17 cells are proinflammatory and are produced under similar environments as a/iTregs. Th17 cells are produced under the influence of TGF-\u03b2 and IL-6 (or IL-21), whereas a/iTregs are produced under the influence of solely TGF-\u03b2, so the difference between a proinflammatory and a pro-regulatory scenario is the presence of a single interleukin. IL-6 or IL-21 is being debated by immunology laboratories as the definitive signaling molecule. Murine studies point to IL-6 whereas human studies have shown IL-21. Foxp3 is the major transcription factor controlling T-regulatory cells (T or CD4 cells). CD4 cells are leukocytes responsible for protecting animals from foreign invaders such as bacteria and viruses. Defects in this gene\u2019s ability to function can cause IPEX syndrome (IPEX), also known as X-linked autoimmunity-immunodeficiency syndrome as well as numerous cancers. While CD4 cells are heavily regulated and require multiple transcription factors such as STAT-5 and AhR in order to become active and function properly, Foxp3 has been identified as the master regulator for T lineage. Foxp3 can either act as a transcriptional activator or suppressor depending on what specific transcriptional factors such as deacetylases and histone acetylases are acting on it. The Foxp3 gene is also known to convert na\u00efve T-cells to T cells, which are capable of an \"in vivo and in vitro\" suppressive capabilities suggesting that Foxp3 is capable of regulating the expression of suppression-mediating molecules. Clarifying the gene targets of Foxp3 could be crucial to the comprehension of the suppressive abilities of T cells.",
            "score": 202.52468717098236
        },
        {
            "docid": "3135637_31",
            "document": "Gut flora . The human immune system creates cytokines that can drive the immune system to produce inflammation in order to protect itself, and that can tamp down the immune response to maintain homeostasis and allow healing after insult or injury. Different bacterial species that appear in gut flora have been shown to be able to drive the immune system to create cytokines selectively; for example \"Bacteroides fragilis\" and some \"Clostridia\" species appear to drive an anti-inflammatory response, while some segmented filamentous bacteria drive the production of inflammatory cytokines. Gut flora can also regulate the production of antibodies by the immune system. One function of this regulation is to cause B cells to class switch to IgA. In most cases B cells need activation from T helper cells to induce class switching; however, in another pathway, gut flora cause NF-kB signaling by intestinal epithelial cells which results in further signaling molecules being secreted. These signaling molecules interact with B cells to induce class switching to IgA. IgA is an important type of antibody that is used in mucosal environments like the gut. It has been shown that IgA can help diversify the gut community and helps in getting rid of bacteria that cause inflammatory responses. Ultimately, IgA maintains a healthy environment between the host and gut bacteria. These cytokines and antibodies can have effects outside the gut, in the lungs and other tissues.",
            "score": 238.97073543071747
        },
        {
            "docid": "38366027_7",
            "document": "Interleukin-1 receptor family . Type I IL-1R (IL-1RI) also known as CD121a is receptor for IL-1\u03b1, IL-1\u03b2 and IL-1RA. IL-1RI signalling is involved in thymocyte proliferation, B cells development, IL-2 and IL-6 production, stress responses, inflammatory responses, sleep regulation and appetite. IL-1RI signalling plays also important role in Th17 development. Studies of human autoimmune diseases such as sclerosis multiplex, Rheumatoid arthritis, psoriasis or autoimmune inflammatory bowel diseases show that defect in IL-1R1 signalling is responsible for Th17-mediated autoimmune diseases.IL-1R signalling is regulated by negative regulators such as inhibitory IL-R1 type II (IL-1RII), soluble IL-1RI and sIL-RII and IL-1Ra. It can be also regulated on the level of downstream signalling molecules by inhibiting recruitment of IRAKs, or by suppression of MyD88 secretion. IL-1R cooperates with receptor accessory protein and both are expressed on T cells, fibroblasts and endothelial cells.",
            "score": 203.39036440849304
        },
        {
            "docid": "28549320_4",
            "document": "Hugh McDevitt . Dr. McDevitt is most well known for his discovery of immune response genes and the first definitive physical map of the Major Histocompatibility Complex (MHC). Specifically, his work focused on how the histocompatibility molecules regulate the immune response and their role in the development and function of the immune system. McDevitt has won awards \"for his landmark discovery and identification of genes that control immune responsiveness, and his subsequent elucidation of mechanisms of antigen recognition and induction of the immune response.\" His research focuses on identifying and understanding how certain cells and specific sequence polymorphisms in a class II MHC molecule initiate diabetes and how T cells can prevent and suppress the transfer of diabetes. Along with Dr. Qing Li, they discovered that interferon-alpha, and immune signal, can trigger the onset of type-1 diabetes. \"A normal process - programmed cell death - causes a normal response,\" McDevitt said. \"But it does this in such a way that, in a small subset of the population, it starts them on the road to type-1 diabetes.\" He is considered an expert in the field of major histocompatibility class II molecules. Currently, his laboratory is working on identifying peptide fragments of proteins which lead to the inflammation and destruction of islet beta cells.  He has also achieved worldwide acclaim for his contributions to arthritis research.",
            "score": 202.56549680233002
        },
        {
            "docid": "2901165_23",
            "document": "Transforming growth factor beta . Studies show that neutralization of TGF-\u03b21 in vitro inhibits the differentiation of helper T cells into T17 cells. The role of TGF-\u03b21 in the generation of T17 cells goes against its dominant conceptualization as an anti-inflammatory cytokine; however, the shared requirement between inflammatory and anti-inflammatory immune cells suggests that an imbalance between these two cell types can be an important link to autoimmunity. Co-activation by IL-6 from activated dendritic cells, which serves to activate the transcription factor STAT3, is required in addition to TGF-\u03b21 for the differentiation of T17 cells. However, the molecular mechanism of T17 differentiation is not well understood. Because T17 cells are distinct from T1 and T2 lineages in that they have been shown to be capable of regulatory functions, this is further evidence of TGF-\u03b21's regulatory function in the immune system.",
            "score": 210.6739548444748
        },
        {
            "docid": "1920949_14",
            "document": "FOXP3 . Mutations or disruptions of the Foxp3 regulatory pathway can lead to organ-specific autoimmune diseases such as autoimmune thyroiditis and type 1 diabetes mellitus. These mutations affect thymocytes developing within the thymus. Regulated by Foxp3, it\u2019s these thymocytes that during thymopoiesis, are transformed into mature Treg cells by the thymus. It was found that patients who have the autoimmune disease systemic lupus erythematosus (SLE) possess Foxp3 mutations that affect the thymopoiesis process, preventing the proper development of T cells within the thymus. These malfunctioning T cells aren\u2019t efficiently being regulated by its transcription factors, which cause them to attack cells that are healthy, leading to these organ-specific autoimmune diseases. Another way that Foxp3 helps keep the autoimmune system at homeostasis is through its regulation of the expression of suppression-mediating molecules. For instance, Foxp3 is able to facilitate the translocation of extracellular adenosine into the cytoplasm. It does this by recruiting CD39, a rate-limiting enzyme that\u2019s vital in tumor suppression to hydrolyze ATP to ADP in order to regulate immunosuppression on different cell populations.",
            "score": 224.78432857990265
        },
        {
            "docid": "70425_40",
            "document": "Inflammation . Delineating how CD4 T cells are depleted and how chronic inflammation and immune activation are induced lies at the heart of understanding HIV pathogenesis\u2013\u2013one of the top priorities for HIV research by the Office of AIDS Research, National Institutes of Health. Recent studies demonstrated that caspase-1-mediated pyroptosis, a highly inflammatory form of programmed cell death, drives CD4 T-cell depletion and inflammation by HIV. These are the two signature events that propel HIV disease progression to AIDS. Pyroptosis appears to create a pathogenic vicious cycle in which dying CD4 T cells and other immune cells (including macrophages and neutrophils) release inflammatory signals that recruit more cells into the infected lymphoid tissues to die. The feed-forward nature of this inflammatory response produces chronic inflammation and tissue injury. Identifying pyroptosis as the predominant mechanism that causes CD4 T-cell depletion and chronic inflammation, provides novel therapeutic opportunities, namely caspase-1 which controls the pyroptotic pathway. In this regard, pyroptosis of CD4 T cells and secretion of pro-inflmammatory cytokines such as IL-1\u03b2 and IL-18 can be blocked in HIV-infected human lymphoid tissues by addition of the caspase-1 inhibitor VX-765, which has already proven to be safe and well tolerated in phase II human clinical trials. These findings could propel development of an entirely new class of \u201canti-AIDS\u201d therapies that act by targeting the host rather than the virus. Such agents would almost certainly be used in combination with ART. By promoting \u201ctolerance\u201d of the virus instead of suppressing its replication, VX-765 or related drugs may mimic the evolutionary solutions occurring in multiple monkey hosts (e.g. the sooty mangabey) infected with species-specific lentiviruses that have led to a lack of disease, no decline in CD4 T-cell counts, and no chronic inflammation.",
            "score": 268.32968616485596
        },
        {
            "docid": "43573647_2",
            "document": "Treg17 cells . Helper T cells are essential part of body's immune system. These cells are divided in many subsets based upon their ability to produce different cytokines. Following the discovery of interleukin-17 (IL-17) producing T helper (Th17) cells as a distinct lineage of T helper cells it became clear that these cells play an important role in the host defense and participate in the pathogenesis of many inflammatory and autoimmune diseases. The Th17 cells can alter their differentiation program ultimately giving rise to either protective or pro-inflammatory pathogenic cells. The protective and non-pathogenic Th17 cells are termed as Treg17 cells.",
            "score": 215.68791723251343
        },
        {
            "docid": "1171686_4",
            "document": "Regulatory T cell . T regulatory cells are a component of the immune system that suppress immune responses of other cells. This is an important \"self-check\" built into the immune system to prevent excessive reactions. Regulatory T cells come in many forms with the most well-understood being those that express CD4, CD25, and FOXP3 (CD4+CD25+ regulatory T cells). These \"Tregs\" are different from helper T cells. Another regulatory T cell subset is Treg17 cells. Regulatory T cells are involved in shutting down immune responses after they have successfully eliminated invading organisms, and also in preventing autoimmunity. CD4+ Foxp3+ regulatory T cells have been called \"naturally occurring\" regulatory T cells to distinguish them from \"suppressor\" T cell populations that are generated in vitro. Additional regulatory T cell populations include Tr1, Th3, CD8+CD28-, and Qa-1 restricted T cells. The contribution of these populations to self-tolerance and immune homeostasis is less well defined. Foxp3 can be used as a good marker for mouse CD4+CD25+ T cells, although recent studies have also shown evidence for Foxp3 expression in CD4+CD25- T cells. In humans, Foxp3 is also expressed by recently activated conventional T-cells and thus does not specifically identify human Tregs.",
            "score": 268.87522768974304
        },
        {
            "docid": "32523145_2",
            "document": "CD8+ cell . CD8+ T cells (commonly known as cytotoxic T cells) are cells of the immune system that contribute to the body's adaptive immune response. These immune cells are characterized by a CD8 protein on their cell surface that allow them to recognize, bind and kill cells infected by intracellular bacteria, intracellular viruses and cancer cells. They are developed in the bone marrow and thymus, and are regulated by transcription factors and signalling components. CD8+ T cells have also been found to play various roles in different diseases.",
            "score": 198.48636865615845
        },
        {
            "docid": "6021647_18",
            "document": "Sulfatide . Each of these different cell types are expressed in cluster of differentiation 1 molecules (CD1). There are 5 subtypes of CD1 molecules that range from a through e. The a through d subtypes are capable of binding to sulfatide. CD1a, CD1b, and CD1c subtypes present lipid antigens to T cells, while CD1d cells present lipids, glycolipids, and lipoproteins to Natural killer T cells. CD1 a through c cell subtypes initiate T helper type 1 and type 2 responses, and they facilitate sulfatide loading onto the surface of the cells. There are two types of cell subtypes that interact with CD1d cells: Type 1 Natural killer T cells and Type 2 Natural killer T cells. Type 2 Natural killer T cells are able to recognize sulfatide/ CD1d tetramers, and as a result, they are activated by different tissues specific forms of sulfatide. Type 2 Natural killer T cells that react with sulfatide help aid in protection from autoimmune disease and ischemic reperfusion. They are capable of such protection because the Type 1 Natural killer T cells can be regulated by Type 2 Natural killer T cells that react with sulfatide by altering how the dendritic cells function.",
            "score": 201.72100591659546
        },
        {
            "docid": "29940688_4",
            "document": "Effects of parasitic worms on the immune system . In the past, helminths were thought to simply suppress T-helper Type 1 (Th1) cells while inducing T-helper Type 2 (Th2) cells. Rook points out that this hypothesis would only explain the regulatory effects of parasitic worms on autoimmune diseases caused by Th1 cells. However, helminths also regulate Th2-caused diseases, such as allergy and asthma. Professor Rook postulates that different parasitic worms suppress different Th types, but always in favor of regulatory T (Treg) cells.",
            "score": 243.84147906303406
        },
        {
            "docid": "45372101_16",
            "document": "Pathology of multiple sclerosis . A protein called Interleukin 12 is responsible for the differentiation of naive T cells into inflammatory T cells. An over production of this protein is what causes the increased inflammation in MS patients. Under normal circumstances, these lymphocytes can distinguish between self and non-self. However, in a person with MS, these cells recognize healthy parts of the central nervous system as foreign and attack them as if they were an invading virus, triggering inflammatory processes and stimulating other immune cells and soluble factors like cytokines and antibodies. Many of the myelin-recognizing T cells belong to a terminally differentiated subset called co-stimulation-independent effector-memory T cells.",
            "score": 223.12854707241058
        },
        {
            "docid": "14157278_3",
            "document": "PD-L1 . Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Normally the immune system reacts to foreign antigens that are associated with exogenous or endogenous danger signals, which triggers a proliferation of antigen-specific CD8+ T cells and/or CD4+ helper cells. The binding of PD-L1 to PD-1 or B7.1 transmits an inhibitory signal that reduces the proliferation of antigen-specific T-cells in lymph nodes, while simultaneously reducing apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells) - further mediated by a lower regulation of the gene Bcl-2.",
            "score": 234.82038486003876
        },
        {
            "docid": "1664060_25",
            "document": "Adaptive immune system . Increasingly, there is strong evidence from mouse and human-based scientific studies of a broader diversity in CD4+ effector T helper cell subsets. Regulatory T (Treg) cells, have been identified as important negative regulators of adaptive immunity as they limit and suppresses the immune system to control aberrant immune responses to self-antigens; an important mechanism in controlling the development of autoimmune diseases. Follicular helper T (Tfh) cells are another distinct population of effector CD4+ T cells that develop from naive T cells post-antigen activation. Tfh cells are specialized in helping B cell humoral immunity as they are uniquely capable of migrating to follicular B cells in secondary lymphoid organs and provide them positive paracrine signals to enable the generation and recall production of high-quality affinity-matured antibodies. Similar to Tregs, Tfh cells also play a role in immunological tolerance as an abnormal expansion of Tfh cell numbers can lead to unrestricted autoreactive antibody production causing severe systemic autoimmune disorders.",
            "score": 297.4806139469147
        },
        {
            "docid": "5672862_36",
            "document": "Lesional demyelinations of the central nervous system . According to the view of most researchers, a special subset of lymphocytes, called T helper cells, specifically Th1 and Th17, play a key role in the development of the lesion. Under normal circumstances, these lymphocytes can distinguish between self and non-self. However, in a person with MS, these cells recognize healthy parts of the central nervous system as foreign and attack them as if they were an invading virus, triggering inflammatory processes and stimulating other immune cells and soluble factors like cytokines and antibodies. Many of the myelin-recognizing T cells belong to a terminally differentiated subset called co-stimulation-independent effector-memory T cells. Recently other type of immune cells, B Cells, have been also implicated in the pathogenesis of MS and in the degeneration of the axons.",
            "score": 203.75226259231567
        },
        {
            "docid": "1171686_24",
            "document": "Regulatory T cell . In addition to the search for novel protein markers, a different method to analyze and monitor Treg cells more accurately has been described in the literature. This method is based on DNA methylation analysis. Only in Treg cells, but not in any other cell type, including activated effector T cells, a certain region within the Foxp3 gene (TSDR, Treg-specific-demethylated region) is found demethylated, which allows to monitor Treg cells through a PCR reaction or other DNA-based analysis methods. Interplay between the Th17 cells and regulatory T cells are important in many diseases like respiratory diseases.",
            "score": 240.73759055137634
        },
        {
            "docid": "2901165_3",
            "document": "Transforming growth factor beta . TGF-\u03b2 is secreted by many cell types, including macrophages, in a latent form in which it is complexed with two other polypeptides, latent TGF-beta binding protein (LTBP) and latency-associated peptide (LAP). Serum proteinases such as plasmin catalyze the release of active TGF-\u03b2 from the complex. This often occurs on the surface of macrophages where the latent TGF-\u03b2 complex is bound to CD36 via its ligand, thrombospondin-1 (TSP-1). Inflammatory stimuli that activate macrophages enhance the release of active TGF-\u03b2 by promoting the activation of plasmin. Macrophages can also endocytose IgG-bound latent TGF-\u03b2 complexes that are secreted by plasma cells and then release active TGF-\u03b2 into the extracellular fluid. Among its key functions is regulation of inflammatory processes, particularly in the gut. TGF-\u03b2 also plays a crucial role in stem cell differentiation as well as T-cell regulation and differentiation. As such, it is a highly researched cytokine in the fields of cancer, auto-immune diseases, and infectious disease.",
            "score": 171.39782452583313
        },
        {
            "docid": "50543321_4",
            "document": "Mark M. Davis . Davis is well known for identifying the first T-cell receptor genes, which are responsible for T lymphocytes ability to \u201csee\u201d foreign entities, solving a major mystery in immunology at that time. He and his research group have made many subsequent discoveries about this type of molecule, subsequently, specifically concerning its biochemical properties and other characteristics, including the demonstration that T cells are able to detect and respond to even a single molecule of their ligand-fragments of antigens bound to Major Histocompatibility Complex cell surface molecules. He also developed a novel way of labeling specific T lymphocytes according to the molecules that they recognize, and this procedure is now an important method in many clinical and basic studies of T cell activity, from new vaccines against cancer to identifying \u201crogue\u201d T cells in autoimmunity. In recent years his has increasingly focused on understanding the human immune system, from developing broad systems biology approaches to inventing new methods to help unravel the complexities of T cell responses to cancer, autoimmunity and infectious diseases.",
            "score": 208.694721698761
        },
        {
            "docid": "33611862_9",
            "document": "Eomesodermin . Eomesodermin/Tbr2 is highly expressed in CD8+ T cells, but not CD4+ T cells. CD4+ T cells are the helper T cells which detect foreign particles in the body, and call CD8+ T cells to facilitate death of the foreign particles. Eomesodermin/Tbr2 was found to play a role in the anti cancer properties of CD8+ T cells. Lack of Eomesodermin/Tbr2, alongside T bet another T box protein caused CD8+ T cells to not penetrate tumors so they could perform their anti cancer duties. Eomesodermin/Tbr2 prevents CD8+ cells from differentiating into other types of T cells, but does not play a role in the production of CD8+ T cells itself. Despite Eomesodermin/Tbr2 playing a role in the ability of CD8+ T cells to penetrate tumors, it only plays a small role in production of Interferon-gamma, which is a molecule that communicates to other immune cells during an immune response.",
            "score": 187.2076609134674
        },
        {
            "docid": "2846331_14",
            "document": "Helminthic therapy . Experimental data support the hypothesis that clinically induced helminthic infections have the ability to alleviate or mitigate immune responses. Most autoimmune disorders are believed to involve hyperactive Th1 or Th17 immune responses that are down regulated by the promotion of a Th2 response by helminths. Helminths secrete immunoregulatory molecules that promote the induction of regulatory T cells while inhibiting the function of antigen presenting cells and other T cells. As such, helminthic therapy attempts to restore homeostasis by shifting a hyperactive Th1 pro-inflammatory response to a Th2 response with reduced inflammation. Human and animal studies have provided evidence of decreased Th1 and Th17 immune responses with a shift to Th2 cytokine production resulting in significantly decreased levels of interleukin 12 and IFNy with simultaneous increases in the regulatory T cells, interleukin 4, interleukin 5 and interleukin 10 of test subjects. These observations indicate that helminth therapy can provide protection against autoimmune disease not only through prevention, since helminths can be present before autoimmune disease develops, but also after autoimmune responses are initiated. Furthermore, responses of type-two T helper cells rarely kill the parasitic worms. Rather, the Th2 response limits the infection by reducing the viability and reproductive capacity of the parasite.",
            "score": 245.5170018672943
        },
        {
            "docid": "6421581_6",
            "document": "RANKL . RANKL is a member of the tumor necrosis factor (TNF) cytokine family, it binds to RANK on cells of the myeloid lineage and functions as a key factor for osteoclast differentiation and activation. RANKL may also bind to osteoprotegerin, a protein secreted mainly by cells of the osteoblast lineage which is a potent inhibitor of osteoclast formation by preventing binding of RANKL to RANK. RANKL also has a function in the immune system, where it is expressed by T helper cells and is thought to be involved in dendritic cell maturation. This protein was shown to be a dendritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor 6 (TRAF6), which indicated this protein may have a role in the regulation of cell apoptosis.",
            "score": 188.43654131889343
        },
        {
            "docid": "2901165_29",
            "document": "Transforming growth factor beta . In normal cells, TGF-\u03b2, acting through its signaling pathway, stops the cell cycle at the G1 stage to stop proliferation, induce differentiation, or promote apoptosis. In many cancer cells, parts of the TGF-\u03b2 signaling pathway are mutated, and TGF-\u03b2 no longer controls the cell. These cancer cells proliferate. The surrounding stromal cells (fibroblasts) also proliferate. Both cells increase their production of TGF-\u03b2. This TGF-\u03b2 acts on the surrounding stromal cells, immune cells, endothelial and smooth-muscle cells. It causes immunosuppression and angiogenesis, which makes the cancer more invasive. TGF-\u03b2 also converts effector T-cells, which normally attack cancer with an inflammatory (immune) reaction, into regulatory (suppressor) T-cells, which turn off the inflammatory reaction. Normal tissue integrity is preserved by feedback interactions between different cell types that express adhesion molecules and secrete cytokines. Disruption of these feedback mechanisms in cancer damages a tissue. When TGF-\u03b2 signaling fails to control NF-\u03baB activity in cancer cells, this has at least two potential effects: first, it enables the malignant tumor to persist in the presence of activated immune cells, and second, the cancer cell outlasts immune cells because it survives in the presence of apoptotic, and anti-inflammatory mediators.",
            "score": 229.35148453712463
        },
        {
            "docid": "1872854_13",
            "document": "Biochemical cascade . The main goal of biochemical cascades in lymphocytes is the secretion of molecules that can suppress altered cells or eliminate pathogenic agents, through proliferation, differentiation and activation of these cells. Therefore, the antigenic receptors play a central role in signal transduction in lymphocytes, because when antigens interact with them lead to a cascade of signal events. These receptors, that recognize the antigen soluble (B cells) or linked to a molecule on Antigen Presenting Cells (T cells), don't have long cytoplasm tails, so they are anchored to signal proteins, which contain a long cytoplasmic tails with a motif that can be phosphorylated (ITAM \u2013 immunoreceptor tyrosine-based activation motif) and resulting in different signal pathways. The antigen receptor and signal protein form a stable complex, named BCR or TCR, in B or T cells, respectively. The family Src is essential for signal transduction in these cells, because it's responsible for phosphorylation of ITAMs. Therefore, Lyn and Lck, in lymphocytes B and T, respectively, phosphorylate ITAMs after the antigen recognition and the conformational change of the receptor, which leads to the binding of Syk/Zap-70 kinases to ITAM and its activation. Syk kinase is specific of lymphocytes B and Zap-70 is present in T cells. After activation of these enzymes, some adaptor proteins are phosphorylated, like BLNK (B cells) and LAT (T cells). These proteins after phosphorylation become activated and allow binding of others enzymes that continue the biochemical cascade. One example of a protein that binds to adaptor proteins and become activated is PLC that is very important in the lymphocyte signal pathways. PLC is responsible for PKC activation, via DAG and Ca, which leads to phosphorylation of CARMA1 molecule, and formation of CBM complex. This complex activates I\u03ba\u03ba kinase, which phosphorylates I-\u03baB, and then allows the translocation of NF-\u03baB to the nucleus and transcription of genes encoding cytokines, for example. Others transcriptional factors like NFAT and AP1 complex are also important for transcription of cytokines. The differentiation of B cells to plasma cells is also an example of a signal mechanism in lymphocytes, induced by a cytokine receptor. In this case, some interleukins bind to a specific receptor, which leads to activation of MAPK/ERK pathway. Consequently, the BLIMP1 protein is translated and inhibits PAX5, allowing immunoglobulin genes transcription and activation of XBP1 (important for the secretory apparatus formation and enhancing of protein synthesis). Also, the coreceptors (CD28/CD19) play an important role because they can improve the antigen/receptor binding and initiate parallel cascade events, like activation o PI3 Kinase. PIP3 then is responsible for activation of several proteins, like vav (leads to activation of JNK pathway, which consequently leads to activation of c-Jun) and btk (can also activate PLC).",
            "score": 187.5434366464615
        },
        {
            "docid": "17339422_14",
            "document": "C3a (complement) . C3a also plays an important role in adaptive immunity, moderating leukocyte production and proliferation. C3a is able to regulate B cell and monocyte production of IL-6 and TNF-\u03b1, and human C3a has been shown to dampen the polyclonal immune response through dose-dependent regulation of B cell molecule production. C3aR signaling along antigen-presenting cells' CD28 and CD40L pathways also plays a role in T cell proliferation and differentiation. C3aR has been shown to be necessary for TH1 cell generation and regulates TH1 IL-10 expression, while an absence of active C3aR on dendritic cells upregulates regulatory T cell production. The absence of C3 has also been shown to decrease IL-2 receptor expression on T cells.",
            "score": 173.90747833251953
        },
        {
            "docid": "54976874_4",
            "document": "Infectious tolerance . During a tolerant state potential effector cells remain but are tightly regulated by induced antigen-specific CD4+ regulatory T cells (iTregs). Many subsets of iTregs play a part in this proces, but CD4CD25FoxP3 Tregs play a key role, because they have the ability to convert conventional T cells into iTregs directly by secretion of the suppressive cytokines TGF-\u03b2, IL-10 or IL-35, or indirectly via dendritic cells (DCs). Production of IL-10 induces the formation of another population of regulatory T cells called Tr1. Tr1 cells are dependent on IL-10 and TGF-\u03b2 as well as Tregs, but differ from them by lacking expression of Foxp3. High IL-10 production is characteristic for Tr1 cells themselves and they also produce TGF-\u03b2. In the presence of IL-10 can be also induced tolerogenic DCs from monocytes, whose production of IL-10 is also important for Tr1 formation. These interactions lead to the production of enzymes such as IDO (indolamine 2,3-dioxygenase) that catabolize essential amino acids. This microenvironment with a lack of essential amino acids together with other signals results in mTOR (mammalian target of rapamycin) inhibition which, particularly in synergy with TGF-\u03b2, direct the induction of new FoxP3 (forkhead box protein 3) expressing Tregs.",
            "score": 216.45160806179047
        }
    ],
    "r": [
        {
            "docid": "1664060_25",
            "document": "Adaptive immune system . Increasingly, there is strong evidence from mouse and human-based scientific studies of a broader diversity in CD4+ effector T helper cell subsets. Regulatory T (Treg) cells, have been identified as important negative regulators of adaptive immunity as they limit and suppresses the immune system to control aberrant immune responses to self-antigens; an important mechanism in controlling the development of autoimmune diseases. Follicular helper T (Tfh) cells are another distinct population of effector CD4+ T cells that develop from naive T cells post-antigen activation. Tfh cells are specialized in helping B cell humoral immunity as they are uniquely capable of migrating to follicular B cells in secondary lymphoid organs and provide them positive paracrine signals to enable the generation and recall production of high-quality affinity-matured antibodies. Similar to Tregs, Tfh cells also play a role in immunological tolerance as an abnormal expansion of Tfh cell numbers can lead to unrestricted autoreactive antibody production causing severe systemic autoimmune disorders.",
            "score": 297.4805908203125
        },
        {
            "docid": "14522621_11",
            "document": "Prostacyclin receptor . IP activators inhibit the adherence of circulating platelets and leukocytes adherence to vascular endothelium thereby blocking their entry into sites of tissue disturbance. The activators also inhibit vascular smooth muscle cells from proliferation by blocking these cells' growth cycle and triggering their apoptosis (i.e. cell death]]. These actions, along with its anti-inflammatory effects, may underlie the ability of IP gene knockout in an ApoE(\u2212/\u2212) mosue model to cause an accelerated rate of developing atherosclerosis. Mouse studies indicate that the PGI-IP axis activates cellular signaling pathways that tend to suppress allergic inflammation. The axis inhibits bone marrow-derived dendritic cells (i.e. antigen-presenting cells that process antigen material, present it on their surfaces for delivery to T cells, and otherwise regulate innate and adaptive immune system responses) from producing pro-inflammatory cytokines (e.g. IL-12, TNF-alpha, IL-1-alpha, and IL-6) while stimulating them to increase production of the anti-inflammatory cytokine, IL-10. IP receptor activation of these cells also blocks their lipopolysaccharide-stimulated expression of pro-inflammatory cell surface proteins (i.e. CD86, CD40, and MHC class II molecules) that are critical for developing adaptive immune responses. IL receptor-activated bone marrow-derived dendritic cells showed a greatly reduced ability to stimulate the proliferation of T helper cell as well as the ability of these cells to produce pro-allergic cytokines (i.e. IL-5 and IL-13)s. In a mouse model of allergic inflammation, PGI reduced the maturation and migration of lung mature dendritic cells to Mediastinal lymph nodes while increasing the egress of immature dendritic cells away from the lung. These effects resulted in a decrease in allergen-induced responses of the cells mediating allergic reactivity, TH-2 cells. These IP-induced responses likely contribute to its apparent function in inhibiting certain mouse inflammation responses as exemplified by the failure of IP receptor deficient mice to develop full lung airway allergic responses to ovalbumin in a model of allergic inflammation.",
            "score": 270.67279052734375
        },
        {
            "docid": "1171686_2",
            "document": "Regulatory T cell . The regulatory T cells (Tregs ), formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Tregs are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells. Tregs express the biomarkers CD4, FOXP3, and CD25 and are thought to be derived from the same lineage as na\u00efve CD4 cells. Because effector T cells also express CD4 and CD25, Tregs are very difficult to effectively discern from effector CD4+, making them difficult to study. Recent research has found that the cytokine TGF\u03b2 is essential for Tregs to differentiate from na\u00efve CD4+ cells and is important in maintaining Treg homeostasis.",
            "score": 270.4185791015625
        },
        {
            "docid": "1171686_4",
            "document": "Regulatory T cell . T regulatory cells are a component of the immune system that suppress immune responses of other cells. This is an important \"self-check\" built into the immune system to prevent excessive reactions. Regulatory T cells come in many forms with the most well-understood being those that express CD4, CD25, and FOXP3 (CD4+CD25+ regulatory T cells). These \"Tregs\" are different from helper T cells. Another regulatory T cell subset is Treg17 cells. Regulatory T cells are involved in shutting down immune responses after they have successfully eliminated invading organisms, and also in preventing autoimmunity. CD4+ Foxp3+ regulatory T cells have been called \"naturally occurring\" regulatory T cells to distinguish them from \"suppressor\" T cell populations that are generated in vitro. Additional regulatory T cell populations include Tr1, Th3, CD8+CD28-, and Qa-1 restricted T cells. The contribution of these populations to self-tolerance and immune homeostasis is less well defined. Foxp3 can be used as a good marker for mouse CD4+CD25+ T cells, although recent studies have also shown evidence for Foxp3 expression in CD4+CD25- T cells. In humans, Foxp3 is also expressed by recently activated conventional T-cells and thus does not specifically identify human Tregs.",
            "score": 268.8752136230469
        },
        {
            "docid": "70425_40",
            "document": "Inflammation . Delineating how CD4 T cells are depleted and how chronic inflammation and immune activation are induced lies at the heart of understanding HIV pathogenesis\u2013\u2013one of the top priorities for HIV research by the Office of AIDS Research, National Institutes of Health. Recent studies demonstrated that caspase-1-mediated pyroptosis, a highly inflammatory form of programmed cell death, drives CD4 T-cell depletion and inflammation by HIV. These are the two signature events that propel HIV disease progression to AIDS. Pyroptosis appears to create a pathogenic vicious cycle in which dying CD4 T cells and other immune cells (including macrophages and neutrophils) release inflammatory signals that recruit more cells into the infected lymphoid tissues to die. The feed-forward nature of this inflammatory response produces chronic inflammation and tissue injury. Identifying pyroptosis as the predominant mechanism that causes CD4 T-cell depletion and chronic inflammation, provides novel therapeutic opportunities, namely caspase-1 which controls the pyroptotic pathway. In this regard, pyroptosis of CD4 T cells and secretion of pro-inflmammatory cytokines such as IL-1\u03b2 and IL-18 can be blocked in HIV-infected human lymphoid tissues by addition of the caspase-1 inhibitor VX-765, which has already proven to be safe and well tolerated in phase II human clinical trials. These findings could propel development of an entirely new class of \u201canti-AIDS\u201d therapies that act by targeting the host rather than the virus. Such agents would almost certainly be used in combination with ART. By promoting \u201ctolerance\u201d of the virus instead of suppressing its replication, VX-765 or related drugs may mimic the evolutionary solutions occurring in multiple monkey hosts (e.g. the sooty mangabey) infected with species-specific lentiviruses that have led to a lack of disease, no decline in CD4 T-cell counts, and no chronic inflammation.",
            "score": 268.3296813964844
        },
        {
            "docid": "1171686_23",
            "document": "Regulatory T cell . A number of different methods are employed in research to identify and monitor Treg cells. Originally, high expression of CD25 and CD4 surface markers was used (CD4CD25 cells). This is problematic as CD25 is also expressed on non-regulatory T cells in the setting of immune activation such as during an immune response to a pathogen. As defined by CD4 and CD25 expression, regulatory T cells comprise about 5\u201310% of the mature CD4 T cell subpopulation in mice and humans, while about 1\u20132% of Treg can be measured in whole blood. The additional measurement of cellular expression of Foxp3 protein allowed a more specific analysis of Treg cells (CD4CD25Foxp3 cells). However, Foxp3 is also transiently expressed in activated human effector T cells, thus complicating a correct Treg analysis using CD4, CD25 and Foxp3 as markers in humans. Therefore, some research groups use another marker, the absence or low-level expression of the surface protein CD127 in combination with the presence of CD4 and CD25. Several additional markers have been described, e.g., high levels of CTLA-4 (cytotoxic T-lymphocyte associated molecule-4) and GITR (glucocorticoid-induced TNF receptor) are also expressed on regulatory T cells, however the functional significance of this expression remains to be defined. There is a great interest in identifying cell surface markers that are uniquely and specifically expressed on all Foxp3-expressing regulatory T cells. However, to date no such molecule has been identified.",
            "score": 267.8785400390625
        },
        {
            "docid": "14884263_5",
            "document": "Systemic inflammation . While SI may be induced by multiple external factors, research suggests that a lack of control by tolerogenic dendritic cells and T-regulatory cells (Treg) is possibly the primary risk factor for the development of SI. In functioning immune responses, T-helper and T-cytotoxic cells are activated by presentation of antigens by antigen-presenting cells (APCs). Chief among these are dendritic cells (DCs). When a DC presents an antigen to a Treg cell, a signal is then sent to the nucleus of the DC, resulting in the production of Indoleamine 2,3- Dioxygenase (IDO). IDO inhibits T cell responses by depleting tryptophan and producing kynurenine, which is toxic to the cell.",
            "score": 265.6849060058594
        },
        {
            "docid": "1171686_19",
            "document": "Regulatory T cell . Although high levels of TILs were initially thought to be important in determining an immune response against cancer, it is now widely recognized that the ratio of Tregs to Teffectors in the tumor microenvironment is a determining factor in the success of the immune response against the cancer. High levels of Tregs in the tumor microenvironment are associated with poor prognosis in many cancers, such as ovarian, breast, renal, and pancreatic cancer. This indicates that Tregs suppress Teffector cells and hinder the body's immune response against the cancer. However, in some types of cancer the opposite is true, and high levels of Tregs are associated with a positive prognosis. This trend is seen in cancers such as colorectal carcinoma and follicular lymphoma. This could be due to Treg's ability to suppress general inflammation which is known to trigger cell proliferation and metastasis . These opposite effects indicate that Treg's role in the development of cancer is highly dependent on both type and location of the tumor.",
            "score": 262.3623352050781
        },
        {
            "docid": "1171686_3",
            "document": "Regulatory T cell . Mouse models have suggested that modulation of Tregs can treat autoimmune disease and cancer and can facilitate organ transplantation. Their implications for cancer are complicated. Tregs tend to be upregulated in individuals with cancer, and they seem to be recruited to the site of many tumors. Studies in both humans and animal models have implicated that high numbers of Tregs in the tumor microenvironment is indicative of a poor prognosis, and Tregs are thought to suppress tumor immunity, thus hindering the body's innate ability to control the growth of cancerous cells. Recent immunotherapy research is studying how regulation of T cells could possibly be utilized in the treatment of cancer.",
            "score": 262.206787109375
        },
        {
            "docid": "232345_29",
            "document": "Butyric acid . Butyrate has established antimicrobial properties in humans that are mediated through the antimicrobial peptide LL-37, which it induces via HDAC inhibition on histone H3. Butyrate increases gene expression of FOXP3 (the transcription regulator for ) and promotes colonic regulatory T cells (Tregs) through the inhibition of class I histone deacetylases; through these actions, it increases the expression of interleukin 10, an anti-inflammatory cytokine. Butyrate also suppresses colonic inflammation by inhibiting the IFN-\u03b3\u2013STAT1 signaling pathways, which is mediated partially through histone deacetylase inhibition. While transient IFN-\u03b3 signaling is generally associated with normal host immune response, chronic IFN-\u03b3 signaling is often associated with chronic inflammation. It has been shown that butyrate inhibits activity of HDAC1 that is bound to the Fas gene promoter in T cells, resulting in hyperacetylation of the Fas promoter and up-regulation of Fas receptor on the T-cell surface. It is thus suggested that butyrate enhances apoptosis of T cells in the colonic tissue and thereby eliminates the source of inflammation (IFN-\u03b3 production).",
            "score": 261.884765625
        },
        {
            "docid": "13506996_11",
            "document": "T helper 17 cell . Additionally, the loss of Th17 cells in the intestine leads to a loss of balance between inflammatory Th17 cells and Treg cells, their anti-inflammatory counterparts. Because of their immunosuppressive properties, they are thought to decrease the anti-viral response to HIV, contributing to pathogenesis. There is more Treg activity compared to Th17 activity, and the immune response to the virus is less aggressive and effective.",
            "score": 261.46942138671875
        },
        {
            "docid": "1171686_13",
            "document": "Regulatory T cell . Tregs play major roles during HIV infection. They suppress the immune system, thus limiting target cells and reducing inflammation, but this simultaneously disrupts the clearance of virus by the cell-mediated immune response and enhances the reservoir by pushing CD4 T cells to a resting state, including infected cells. Additionally, Tregs can be infected by HIV, increasing the size of the HIV reservoir directly. Thus, Tregs are being investigated as targets for HIV cure research.",
            "score": 258.4112243652344
        },
        {
            "docid": "407814_24",
            "document": "Hygiene hypothesis . An alternative explanation is that the developing immune system must receive stimuli (from infectious agents, symbiotic bacteria, or parasites) to adequately develop regulatory T cells. Without that stimuli it becomes more susceptible to autoimmune diseases and allergic diseases, because of insufficiently repressed T1 and T2 responses, respectively. For example, all chronic inflammatory disorders show evidence of failed immunoregulation. Secondly, helminths, non-pathogenic ambient pseudocommensal bacteria or certain gut commensals and probiotics, drive immunoregulation. They block or treat models of all chronic inflammatory conditions. Thirdly, some such organisms (or molecules that they secrete), specifically expand populations of regulatory T cells (Treg), or cause dendritic cells to switch to regulatory forms that preferentially drive immunoregulation. Finally, when multiple sclerosis patients become infected with helminths, the disease stops progressing and circulating myelin-recognising regulatory T cells appear in the peripheral blood. This indicates that helminths act as adjuvants for regulatory T cells. This observation led to clinical trials.",
            "score": 257.5050354003906
        },
        {
            "docid": "37619510_6",
            "document": "Fiona Powrie . Work from the Powrie lab. identified that Treg could not alone prevent inflammatory bowel disease but could actually cure established inflammation. Furthermore, Powrie was among the first to identify a population of CD4+CD25+ T cells in human peripheral blood that possessed regulatory capacity, confirming these cells as a bona fide T cell subset in humans.",
            "score": 257.44256591796875
        },
        {
            "docid": "14162110_10",
            "document": "Prostaglandin EP4 receptor . Activation of EP suppresses the production of IL-12p70 and increases IL-23 thereby promoting development of IL-17-producing Th17 cells, a subset of pro-inflammatory T helper cells that serves to maintain mucosal barriers, clear mucosal surfaces of pathogens, and contribute to autoimmune and inflammatory disorders. Its activation also: a) supports the development of Regulatory T cells (i.e. suppressor T cells that modulate the immune system to maintain tolerance to self-antigens and prevent autoimmune disease); b) stimulate Dendritic cells (i.e. antigen-presenting cells located primarily in the skin and mucus membranes) to mature, migrate, and direct the early stage of immune responses; c) inhibit antibody-producing B cells from proliferating; d) suppresses the development of Atherosclerosis plaques by promoting the death (i.e. apoptosis) of plaque-bound pro-inflammatory macrophages; e) increases the survival of neurons in an inflammation-based model of Alzheimer's disease; f) increases local arteriole and capillary blood flow to cause, for example, site-specific signs of inflammation such as redness, heat, and swelling in rodent models; and g) suppresses sensory Dorsal root ganglion neurons from signaling inflammation-induced pain (i.e. allodynia and hyperalgesia) and has been used successfully to block the osteoarthritis pain in dogs.",
            "score": 254.92831420898438
        },
        {
            "docid": "41479084_12",
            "document": "Altered Schaedler flora . Intestinal homeostasis is maintained by host-microbe interactions and host immunity. This is critical for digestion of food and protection against pathogens. Bouskra, \"et al.\" studied the regulation of intestinal flora and the immune system. They found IgA producing B cells in the Peyer\u2019s patches, intestinal lymphoid tissues and follicles, and mesenteric lymph nodes. They used ASF to test the maturation of lymphoid follicles into large B cell clusters by the toll-like receptor signaling. In another study, the innate detection system generates adaptive immune system to maintain intestinal homeostasis. Geuking, \"et al.\" examined the role of regulatory T cells in limiting microbe-triggered intestinal inflammation and the T cell compartment. Using ASF, they found intestinal colonization resulted in activation and generation of colonic Treg cells. In germfree mice, Th17 and Th1 response dominate.",
            "score": 254.65545654296875
        },
        {
            "docid": "10240143_4",
            "document": "Fascin . Fascin binds beta-catenin, and colocalizes with it at the leading edges and borders of epithelial and endothelial cells. The role of Fascin in regulating cytoskeletal structures for the maintenance of cell adhesion, coordinating motility and invasion through interactions with signalling pathways is an active area of research especially from the cancer biology perspective. Fascin localizes to actin-rich protrusions at the cell surface called filopodia. Recent study shows that fascin also localizes to invadopodia, membrane protrusions formed at the adherent cell surface that facilitate extracellular matrix (ECM) invasion, this provide a potential molecular mechanism for how fascin increases the invasiveness of cancer cells since fascin expression is upregulated in a spectrum of cancers. Studies have also shown that Fascin plays a major role in immune suppression. T regulatory cell adhesion to antigen presenting dendritic cell causes sequestration of Fascin-1, an actin-bundling protein essential for immunological synapse formation, and skews Fascin-1\u2013dependent actin polarization in antigen presenting dendritic cells toward the T reg cell adhesion zone. Although it is reversible upon T regulatory cell disengagement, this sequestration of essential cytoskeletal components causes a lethargic state of dendritic cells, leading to reduced T cell priming. This suggests Treg-mediated suppression of antigen presenting cells is a multi-step process. In addition to CTLA-4 CD80/CD86 interaction fascin dependent polarization of cytoskeleton towards dendritic cell Treg immune synapse play a pivotal role. In normal tissue, inflammation and the immune response would be limited by secretion of TGF-\u03b2. TGF-\u03b2 on the one hand induces fascin expression, but on the other hand, restricts activity of transcription factor NF-\u03baB. This results to limited fascin expression and allows tissue to rebuild epithelial barriers. In cancer, instead, TGF-\u03b2 does not restrict NF-\u03baB activity, and both can increase fascin expression, disrupting tissue structure and function.",
            "score": 254.17364501953125
        },
        {
            "docid": "14170638_6",
            "document": "CD69 . CD69 expression has been associated with both regulatory T cell (Treg) and memory T cell precursors. Treg precursors exit the thymus expressing CD69 and complete differentiation into Treg cells in peripheral tissues when they encounter antigens and other cytokines, like IL-2. Through the JAK/STAT signaling pathway, CD69 activation also induces the production of TGF-\u03b2 as well as IL-2, which contribute to the differentiation of Treg cells as mentioned above. Furthermore, CD69 is also known to be upregulated by NF-\u03baB signaling at the onset of an immune response. A prolonged immune response is then maintained by the non-canonical NF-\u03baB pathway, which in turn is associated with Treg differentiation.",
            "score": 253.69020080566406
        },
        {
            "docid": "29940688_5",
            "document": "Effects of parasitic worms on the immune system . Professor Rook explains that these regulatory T cells release interleukins that fight inflammation. In the Journal of Biomedicine and Biotechnology, Dr. Osada et al. note that macrophages induced by Treg cells fight not only the parasitic disease, but also resist the immune system's response to allergens and the body. According to Dr. Hopkin, the author of a 2009 \"Parasite Immunology\" article on asthma and parasitic worms, other immunoregulatory mechanisms are also activated, including Mast cells, eosinophils, and cytokines that invoke a strong immunoglobulin E (IgE) response. All these fight a hyperactive immune response, reduce the inflammation throughout the body, and thus lead to less severe autoimmune diseases.",
            "score": 253.447021484375
        },
        {
            "docid": "14958_58",
            "document": "Immune system . The immune system, particularly the innate component, plays a decisive role in tissue repair after an insult. Key actors include macrophages and neutrophils, but other cellular actors, including \u03b3\u03b4 T cells, innate lymphoid cells (ILCs), and regulatory T cells (Tregs), are also important. The plasticity of immune cells and the balance between pro-inflammatory and anti-inflammatory signals are crucial aspects of efficient tissue repair. Immune components and pathways are involved in regeneration as well, for example in amphibians. According to one hypothesis, organisms that can regenerate could be less immunocompetent than organisms that cannot regenerate.",
            "score": 252.1403045654297
        },
        {
            "docid": "170417_10",
            "document": "T cell . Regulatory T cells can develop either during normal development in the thymus, and are then known as thymic Treg cells, or can be induced peripherally and are called peripherally derived Treg cells. These two subsets were previously called \"naturally occurring\", and \"adaptive\" or \"induced\", respectively. Both subsets require the expression of the transcription factor FOXP3 which can be used to identify the cells. Mutations of the \"FOXP3\" gene can prevent regulatory T cell development, causing the fatal autoimmune disease IPEX.",
            "score": 251.7719268798828
        },
        {
            "docid": "13208464_6",
            "document": "ITGAE . Tregs are important for decreasing the immune response and appear to play a crucial role in the prevention of autoimmune diseases. Tregs are defined as CD4/CD25/Foxp3 cells. Some CD4/FoxP3 cells also express CD103 and have been attributed regulatory activity. It is unclear whether the presence of CD103 on Treg cells represents a specialized feature for Treg, or Treg differentiation of IEL T cells.",
            "score": 249.8606414794922
        },
        {
            "docid": "5024592_13",
            "document": "Immune tolerance . Those self-reactive T cells that escape intrathymic negative selection in the thymus can inflict cell injury unless they are deleted or effectively muzzled in the peripheral tissue chiefly by nTreg cells (see central tolerance above). Appropriate reactivity toward certain antigens can also be quieted by induction of tolerance after repeated exposure, or exposure in a certain context. In these cases, there is a differentiation of na\u00efve CD4+ helper T cells into induced Treg cells (iTreg cells) in the peripheral tissue or nearby lymphoid tissue (lymph nodes, mucosal-associated lymphoid tissue, etc.). This differentiation is mediated by IL-2 produced upon T cell activation, and TGF-\u03b2 from any of a variety of sources, including tolerizing dendritic cells (DCs), other antigen presenting cells, or in certain conditions surrounding tissue. Treg cells are not the only cells that mediate peripheral tolerance. Other regulatory immune cells include T cell subsets similar to but phenotypically distinct from Treg cells, including TR1 cells that make IL-10 but do not express Foxp3, TGF-\u03b2-secreting TH3 cells, as well as other less well-characterized cells that help establish a local tolerogenic environment. B cells also express CD22, a non-specific inhibitor receptor that dampens B cell receptor activation. A subset of B regulatory cells that makes IL-10 and TGF-\u03b2 also exists. Some DCs can make Indoleamine 2,3-dioxygenase (IDO) that depletes the amino acid tryptophan needed by T cells to proliferate and thus reduce responsiveness. DCs also have the capacity to directly induce anergy in T cells that recognize antigen expressed at high levels and thus presented at steady-state by DCs. In addition, FasL expression by immune privileged tissues can result in activation-induced cell death of T cells.",
            "score": 249.68914794921875
        },
        {
            "docid": "5024592_14",
            "document": "Immune tolerance . The involvement of T cells, later classified as Treg cells, in immune tolerance was recognized in 1995 when animal models showed that CD4+ CD25+ T cells were necessary and sufficient for the prevention of autoimmunity in mice and rats. Initial observations showed removal of the thymus of a newborn mouse resulted in autoimmunity, which could be rescued by transplantation of CD4+ T cells. A more specific depletion and reconstitution experiment established the phenotype of these cells as CD4+ and CD25+. Later in 2003, experiments showed that Treg cells were characterized by the expression of the Foxp3 transcription factor, which is responsible for the suppressive phenotype of these cells.",
            "score": 247.26573181152344
        },
        {
            "docid": "37619510_5",
            "document": "Fiona Powrie . Powrie performed post-doctoral studies with Robert L. Coffman at DNAX in Palo Alto, California. Here, she extended her earlier work in rats to mice and developed the \u201cT cell transfer\u201d model, one of the most prominent models of intestinal inflammation where transfer of CD4+CD45RBhi T cells to Rag deficient or SCID mice led to the development of severe intestinal inflammation and wasting disease. This could be prevented by transfer of CD4+CD45RBlo T cells. Using this model Powrie further identified the pathogenic role played by IFN-\u03b3 and TNF-\u03b1 in intestinal inflammation and the therapeutic potential of IL-10 and highlighted the requirement for TGF-\u03b2 in the prevention of colitis by the CD4+CD45RBlo regulatory T cell subset  Upon returning to the University of Oxford in 1996, first to the Nuffield Department of Surgery and later, the Sir William Dunn School of Pathology, Powrie used the T cell transfer model to identify the suppressive mechanisms used by regulatory T cells to prevent intestinal inflammation including the requirements for CTLA-4 and the capacity of Treg to prevent colitis driven by innate immune cells as well as CD4+ T cells. Focusing on pathogenic mechanisms the Powrie lab. identified the critical role played by the cytokine IL-23 in driving pathology in the intestine",
            "score": 245.79269409179688
        },
        {
            "docid": "8476171_9",
            "document": "Glatiramer acetate . Glatiramer acetate is a random polymer (average molecular mass 6.4\u00a0kD) composed of four amino acids found in myelin basic protein. The mechanism of action for glatiramer acetate is not fully elucidated. It is thought to act by modifying immune processes that are currently believed to be responsible for the pathogenesis of MS. Administration of glatiramer acetate shifts the population of T cells from proinflammatory Th1 T-cells to regulatory Th2 T-cells that suppress the inflammatory response. Given its resemblance to myelin basic protein, glatiramer acetate may act as a decoy, diverting an autoimmune response against myelin. This hypothesis is supported by findings of studies that have been carried out to explore the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a condition induced in several animal species through immunization against central nervous system derived material containing myelin and often used as an experimental animal model of MS. Studies in animals and in vitro systems suggest that upon its administration, glatiramer acetate-specific regulatory T cells (Tregs) are induced and activated in the periphery, inhibiting the inflammatory reaction to myelin basic protein.",
            "score": 245.5650177001953
        },
        {
            "docid": "2846331_14",
            "document": "Helminthic therapy . Experimental data support the hypothesis that clinically induced helminthic infections have the ability to alleviate or mitigate immune responses. Most autoimmune disorders are believed to involve hyperactive Th1 or Th17 immune responses that are down regulated by the promotion of a Th2 response by helminths. Helminths secrete immunoregulatory molecules that promote the induction of regulatory T cells while inhibiting the function of antigen presenting cells and other T cells. As such, helminthic therapy attempts to restore homeostasis by shifting a hyperactive Th1 pro-inflammatory response to a Th2 response with reduced inflammation. Human and animal studies have provided evidence of decreased Th1 and Th17 immune responses with a shift to Th2 cytokine production resulting in significantly decreased levels of interleukin 12 and IFNy with simultaneous increases in the regulatory T cells, interleukin 4, interleukin 5 and interleukin 10 of test subjects. These observations indicate that helminth therapy can provide protection against autoimmune disease not only through prevention, since helminths can be present before autoimmune disease develops, but also after autoimmune responses are initiated. Furthermore, responses of type-two T helper cells rarely kill the parasitic worms. Rather, the Th2 response limits the infection by reducing the viability and reproductive capacity of the parasite.",
            "score": 245.51699829101562
        },
        {
            "docid": "29940688_4",
            "document": "Effects of parasitic worms on the immune system . In the past, helminths were thought to simply suppress T-helper Type 1 (Th1) cells while inducing T-helper Type 2 (Th2) cells. Rook points out that this hypothesis would only explain the regulatory effects of parasitic worms on autoimmune diseases caused by Th1 cells. However, helminths also regulate Th2-caused diseases, such as allergy and asthma. Professor Rook postulates that different parasitic worms suppress different Th types, but always in favor of regulatory T (Treg) cells.",
            "score": 243.8414764404297
        },
        {
            "docid": "13780711_10",
            "document": "Peripheral tolerance . Dendritic cells (DCs) are a major cell population responsible for the initiation of adaptive immune response. However, immature DCs are able to induce both CD4 and CD8 tolerance. These immature DCs acquire the antigen from the peripheral tissues (by endocytosis of apoptotic cells) and present it to the naive T cells in the secondary lymphoid organs. If the T cell recognizes the antigen, it is either deleted or converted to Treg. Furthermore, BTLA DCs were identified as a specialized population of antigen presenting cells (APCs), responsible for Treg conversion. Nonetheless, upon maturation (for example during the infection) DCs largely lose their tolerogenic capabilities.",
            "score": 243.78785705566406
        },
        {
            "docid": "2344516_26",
            "document": "NF-\u03baB . Because NF-\u03baB controls many genes involved in inflammation, it is not surprising that NF-\u03baB is found to be chronically active in many inflammatory diseases, such as inflammatory bowel disease, arthritis, sepsis, gastritis, asthma, atherosclerosis and others. It is important to note though, that elevation of some NF-\u03baB activators, such as osteoprotegerin (OPG), are associated with elevated mortality, especially from cardiovascular diseases. Elevated NF-\u03baB has also been associated with schizophrenia. Recently, NF-\u03baB activation has been suggested as a possible molecular mechanism for the catabolic effects of cigarette smoke in skeletal muscle and sarcopenia. Research has shown that during inflammation the function of a cell depends on signals it activates in response to contact with adjacent cells and to combinations of hormones, especially cytokines that act on it through specific receptors. A cells\u2019 phenotype within a tissue develops through mutual stimulation of feedback signals that coordinate its function with other cells; this is especially evident during reprogramming of cell function when a tissue is exposed to inflammation, because cells alter their phenotype, and gradually express combinations of genes that prepare the tissue for regeneration after the cause of inflammation is removed. Particularly important are feedback responses that develop between tissue resident cells, and circulating cells of the immune system. Fidelity of feedback responses between diverse cell types and the immune system depends on the integrity of mechanisms that limit the range of genes activated by NF-\u03baB, allowing only expression of genes which contribute to an effective immune response and subsequently, a complete restoration of tissue function after resolution of inflammation. In cancer, mechanisms that regulate gene expression in response to inflammatory stimuli are altered to the point that a cell ceases to link its survival with the mechanisms that coordinate its phenotype and its function with the rest of the tissue. This is often evident in severely compromised regulation of NF-\u03baB activity, which allows cancer cells to express abnormal cohorts of NF-\u03baB target genes. This results in not only the cancer cells functioning abnormally: cells of surrounding tissue alter their function and cease to support the organism exclusively. Additionally, several types of cells in the microenvironment of cancer may change their phenotypes to support cancer growth. Inflammation, therefore, is a process that tests the fidelity of tissue components because the process that leads to tissue regeneration requires coordination of gene expression between diverse cell types.",
            "score": 243.4745635986328
        },
        {
            "docid": "1920949_2",
            "document": "FOXP3 . FOXP3 (forkhead box P3), also known as scurfin, is a protein involved in immune system responses. A member of the FOX protein family, FOXP3 appears to function as a master regulator of the regulatory pathway in the development and function of regulatory T cells. Regulatory T cells generally turn the immune response down. In cancer, an excess of regulatory T cell activity can prevent the immune system from destroying cancer cells. In autoimmune disease, a deficiency of regulatory T cell activity can allow other autoimmune cells to attack the body's own tissues.",
            "score": 241.50424194335938
        },
        {
            "docid": "38751964_20",
            "document": "Mucosal associated invariant T cell . For individuals with the autoimmune disease multiple sclerosis (MS), the immune system attacks the myelin sheaths covering nerves, causing impaired nerve signaling. While T helper 1 (Th1) and T helper 17 (Th17) cells have been reported as contributors to MS by increasing inflammation at myelin sites, human MAIT cells have also been observed at these sites. In addition, during periods of myelin degeneration, MAIT cell levels in the peripheral blood have been found to decrease, suggesting their tendency to migrate to sites of MS-related inflammation. At these sites, MAIT cells further contribute to the autoimmune response by secreting pro-inflammatory cytokines. However, in contrast to these findings, MAIT cells have also been found to display a protective role in MS by limiting Th1 cell secretion of IFN-\u03b3 at sites of inflammation. To explain these findings, the role of MAIT cells in MS must be further explored.",
            "score": 241.32408142089844
        }
    ]
}